StockIQpro
NASDAQ:ACET

Adicet Bio, Inc.

Track all markets on TradingView
Track all markets on TradingView

Adicet Bio, Inc. reported net income of −$116.8M in fiscal 2025. Free cash flow was −$97.0M, and the diluted share count rose 25.5%.Summary generated from Adicet Bio, Inc.'s SEC filings. Latest annual report filed Mar 12, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−67.6%
Debt / equityn/a
Free cash flow−$97.0M
FCF marginn/a
Share count change+25.5%

Financials

Fiscal years, $M
Item20212022202320242025
Revenuen/an/an/an/an/a
Operating income−61−73−152−128−122
Net income−62−70−143−117−117
Free cash flow−64−62−98−93−97

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations